Neuronetics rises on Q2 revenue beat, forecast raise

Neuronetics

02/08/2022 17:35

** Shares of Neuronetics Inc  STIM.O  rise 1.9% to $4.33 in
afternoon trade
    ** STIM's Q2 revenue of $16.3 mln beats Refinitiv IBES
estimates, helped by strong demand for its NeuroStar system for
the treatment of mental health disorders  urn:newsml:reuters.com:*:nGNX8pnT7p
    ** Medical device maker raises lower end of its 2022 revenue
forecast range
    ** Now expects FY revenue between $60 mln and $62 mln vs
prior forecast of $58 mln to $62 mln
    ** Stock down nearly 3% YTD, including session moves

 (Reporting by Amruta Khandekar)
 ((Amruta.Khandekar@thomsonreuters.com;))